Viewing StudyNCT06177522



Ignite Creation Date: 2024-05-06 @ 7:53 PM
Last Modification Date: 2024-10-26 @ 3:16 PM
Study NCT ID: NCT06177522
Status: RECRUITING
Last Update Posted: 2023-12-20
First Post: 2023-12-11

Brief Title: Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer
Sponsor: Jinling Hospital China
Organization: Jinling Hospital China

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-12
Start Date Type: ESTIMATED
Primary Completion Date: 2024-12
Primary Completion Date Type: ESTIMATED
Completion Date: 2026-12
Completion Date Type: ESTIMATED
First Submit Date: 2023-12-11
First Submit QC Date: December 11 2023
Study First Post Date: 2023-12-20
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-08-15
Last Update Post Date: 2023-12-20
Last Update Post Date Type: ACTUAL